Polyfunctional analysis of human t cell responses: Importance in vaccine immunogenicity and natural infection

Springer Seminars in Immunopathology

Volumn 28, Issue 3, 2006, Pages 209-219

  Makedonas, George ^a   Betts, Michael R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; DNA VACCINE; GAMMA INTERFERON; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VACCINIA VACCINE;

ADENOVIRUS 5; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; ENZYME LINKED IMMUNOSPOT ASSAY; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION CONTROL; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; PHENOTYPE; POXVIRUS; PRIORITY JOURNAL; REVIEW; VACCINIA; VIRUS REPLICATION; VIRUS VECTOR;

AIDS VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOKINES; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; VIRAL VACCINES; VIRUS DISEASES;

EID: 33751071052     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-006-0025-4     Document Type: Review

References (124)

1. Richman DD et al (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 100(7):4144-4149
2. Zolla-Pazner S (2004) Identifying epitopes of HIV-1 that induce protective antibodies. Nat Rev Immunol 4(3):199-210
3. Wei X et al (2003) Antibody neutralization and escape by HIV-1. Nature 422(6929):307-312
4. Kwong PD et al (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420(6916):678-682
5. Wyatt R et al (1998) The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393(6686):705-711
6. Back NK et al (1994) An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 199(2):431-438
7. Mascola JR et al (2000) Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6(2):207-210
8. Trkola A et al (2005) Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat Med 11(6):615-622
9. Amyes E et al (2003) Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 198(6):903-911
10. Callan MF (2003) The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus. Viral Immunol 16(1):3-16
11. Belz GT, Doherty PC (2001) Virus-specific and bystander CD8+ T-cell proliferation in the acute and persistent phases of a gammaherpesvirus infection. J Virol 75(9):4435-4438
12. Doherty PC et al (2001) Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 356 (1408):581-593
13. Gillespie GM et al (2000) Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol 74(17):8140-8150
14. Moriyama T et al (1990) Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248(4953):361-364
15. Guidotti LG et al (1996) Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4(1):25-36
16. Guidotti LG et al (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284(5415):825-829
17. Lechner F et al (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191(9):1499-1512
18. Schmitz JE et al (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283(5403):857-860
19. Jin X et al (1999) Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189(6):991-998
20. Schmitz JE et al (2005) Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIV-mac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques. J Virol 79(13):8131-8141
21. Vaccari M et al (2005) Vaccine-induced CD8+ central memory T cells in protection from simian AIDS. J Immunol 175(6):3502-3507
22. Boyer JD et al (2006) Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239. Vaccine 24(21):4498-4502
23. Walker BD et al (1987) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328(6128):345-348
24. Nixon DF et al (1998) HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336(6198):484-487
25. Salerno-Goncalves R et al (1998) Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells. Immunol Lett 64(2-3):71-77
26. Borrow P et al (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68(9):6103-6110
27. Koup RA et al (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68(7):4650-4655
28. Goulder PJ et al (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3(2):212-217
29. Kaslow RA et al (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2(4):405-411
30. Trachtenberg E et al (2003) Advantage of rare HLA supertype in HIV disease progression. Nat Med 9(7):928-935
31. Migueles SA et al (2000) HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 97(6):2709-2714
32. Price DA et al (1997) Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 94(5):1890-1895
33. Borrow P et al (1997) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3(2):205-211
34. Evans DT et al (1999) Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med 5(11):1270-1276
35. Allen TM et al (2000) Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407(6802):386-390
36. Henkart P et al (1985) The role of cytoplasmic granules in cytotoxicity by large granular lymphocytes and cytotoxic T lymphocytes. Adv Exp Med Biol 184:121-138
37. Henkart PA (1985) Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol 3:31-58
38. Bossi G, Griffiths GM (1999) Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 5(1):90-96
39. Appay V et al (2000) HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192(1):63-75
40. Betts MR et al (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281(1-2):65-78
41. Peters PJ et al (1991) Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 173(5):1099-1109
42. Rubio V et al (2003) Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 9(11):1377-1382
43. Wagner L et al (1998) Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391(6670):908-911
44. Catalfamo M et al (2004) Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20(2):219-230
45. Picker LJ et al (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86(4):1408-1419
46. Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258-267
47. Schroder K et al (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163-189
48. Schreiber RD et al (1985) Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. J Immunol 134(3):1609-1618
49. Suzuki Y et al (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240 (4851):516-518
50. Huang S et al (1993) Immune response in mice that lack the interferon-gamma receptor. Science 259(5102):1742-1745
51. Kamijo R et al (1993) Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 178(4):1435-1440
52. van den Broek MF et al (1995) Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 148:5-18
53. Pearl JE et al (2001) Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. Cell Immunol 211(1):43-50
54. Zamanian-Daryoush M et al (2000) NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol Cell Biol 20(4):1278-1290
55. Wong AH et al (1997) Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J 16(6):1291-1304
56. Meurs E et al (1990) Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62(2):379-390
57. Ramana CV et al (2000) Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. Embo J 19(2):263-272
58. Tsujimoto M, Yip YK Vilcek J (1986) Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. J Immunol 136(7):2441-2444
59. Xu X et al (1998) IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 58(13):2832-2837
60. Zheng H et al (2002) [Interferon-gamma up-regulates Fas expression and increases Fas-mediated apoptosis in tumor cell lines]. Di Yi Jun Yi Da Xue Xue Bao 22(12):1090-1092
61. Alcami A, Smith GL (1995) Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69(8):4633-4639
62. Khan S et al (2004) A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol 78(4):1831-1842
63. Dick TP et al (1996) Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86(2):253-262
64. Groettrup M et al (1996) A role for the proteasome regulator PA28alpha in antigen presentation. Nature 381(6578):166-168
65. Cramer LA, Nelson SL, Klemsz MJ (2000) Synergistic induction of the Tap-1 gene by IFN-gamma and lipopolysaccharide in macrophages is regulated by STAT1. J Immunol 165(6):3190-3197
66. Decker T et al (2002) IFNs and STATs in innate immunity to microorganisms. J Clin Invest 109(10):1271-1277
67. Epperson DE et al (1992) Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol 149(10):3297-32301
68. Wallach D, Fellous M, Revel M (1982) Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299(5886):833-836
69. Chang CH et al (1992) The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 35(6):378-384
70. Pernis A et al (1995) Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 269(5221):245-247
71. Kaech SM et al (2002) Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111(6):837-851
72. Liu F, Whitton JL (2005) Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. J Immunol 174(10):5936-5940
73. Iyasere C et al (2003) Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol 77(20):10900-10909
74. Younes SA et al (2003) HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 198(12):1909-1922
75. Kolb WP, Granger GA (1968) Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci USA 61(4):1250-1255
76. Carswell EA et al (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72(9):3666-3670
77. Pfeffer K (2003) Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 14(3-4):185-191
78. Kriegler M et al (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53(1):45-53
79. Moss ML et al (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385(6618):733-736
80. Idriss HT, Naismith JH (2000) TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 50(3):184-195
81. Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334(26):1717-17125
82. Feldmann M et al (1995) TNF alpha is an effective therapeutic target for rheumatoid arthritis. Ann N Y Acad Sci 766:272-278
83. Ogg GS et al (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279(5359):2103-2106
84. Addo MM et al (2003) Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77(3):2081-2092
85. Masemola A et al (2004) Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol 78(7):3233-3243
86. Betts MR et al (2001) Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 75(24):11891-11983
87. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264(5164):1415-1421
88. Wu CY et al (2002) Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat Immunol 3(9):852-858
89. Jansson M et al (1996) Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci USA 93(26):15382-15387
90. Locati M, Murphy PM (1999) Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu Rev Med 50:425-440
91. Lee B, Montaner LJ (1999) Chemokine immunobiology in HIV-1 pathogenesis. J Leukoc Biol 65(5):552-565
92. Grant MD, Smail FM, Rosenthal KL (1994) Cytotoxic T-lymphocytes that kill autologous CD4+ lymphocytes are associated with CD4+ lymphocyte depletion in HIV-1 infection. J Acquir Immune Defic Syndr 7(6):571-579
93. Kottilil S et al (2000) Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells. J Clin Immunol 20(3):175-186
94. Matloubian M, Concepcion RJ, Ahmed R (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68(12):8056-8063
95. Battegay M et al (1994) Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol 68(7):4700-4704
96. von Herrath MG et al (1996) CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 70(2):1072-1079
97. Rosenberg ES et al (1997) Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278(5342):1447-1450
98. Lichterfeld M et al (2004) Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 200(6):701-712
99. Migueles SA et al (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in non-progressors. Nat Immunol 3(11):1061-1068
100. Wherry EJ et al (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77(8):4911-4927
101. Xiong Y et al (2001) Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation. J Virol 75(6):3028-3033
102. Vogel TU et al (2001) Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection. J Virol 75(5):2458-2461
103. Schlaak JF et al (1999) The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. J Hepatol 30(3):353-358
104. Gruener NH et al (2001) Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 75(12):5550-5558
105. Lee PP et al (1999) Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5(6):677-685
106. Sallusto F et al (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754):708-712
107. Unsoeld H et al (2002) Cutting edge: CCR7+ and CCR7-memory T cells do not differ in immediate effector cell function. J Immunol 169(2):638-641
108. Ravkov EV, Myrick CM, Altman JD (2003) Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J Immunol 170(5):2461-2468
109. Ellefsen K et al (2002) Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections. Eur J Immunol 32(12):3756-3764
110. Hislop AD et al (2001) EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J Immunol 167(4):2019-2029
111. Pitcher CJ et al (2002) Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168(1):29-43
112. Betts MR et al (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells. Blood 107(12):4781-4789
113. Cousens LP, Orange JS, Biron CA (1995) Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. J Immunol 155(12):5690-5699
114. Mizuochi T et al (1989) Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus. J Immunol 142(1):270-273
115. Kasaian MT, Biron CA (1989) The activation of IL-2 transcription in L3T4+ and Lyt-2+ lymphocytes during virus infection in vivo. J Immunol 142(4):1287-1292
116. Kristensen NN, Christensen JP, Thomsen AR (2002) High numbers of IL-2-producing CD8+ T cells during viral infection: correlation with stable memory development. J Gen Virol 83(Pt 9):2123-2133
117. La Gruta NL, Turner SJ, Doherty PC (2004) Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity. J Immunol 172(9):5553-5560
118. Harari A et al (2004) Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103(3):966-972
119. Mestan J et al (1986) Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323(6091):816-819
120. Guidotti LG et al (1999) Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med 189(10):1555-1564
121. Sandberg JK, Fast NM, Nixon DF (2001) Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. J Immunol 167(1):181-187
122. Gea-Banacloche JC et al (2000) Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 165(2):1082-1092
123. De Rosa SC et al (2004) Vaccination in humans generates broad T cell cytokine responses. J Immunol 173(9):5372-5380
124. Betts MR et al (2005) Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci USA 102(12):4512-4517